4DMedical EBITDA per Share

What does 4DMedical do? 4DMedical Ltd. commercializes its XV Technology, a four-dimensional lung imaging platform, through FDA-cleared XV Lung Ventilation Analysis Software (XV LVA) and CT LVAS, delivered via a software-as-a-service model. The company sells these products to hospitals and clinics, including I-MED Radiology Network, which operates approximately 250 clinics nationwide. XV LVAS and CT LVAS reports are generated using the company’s software, leveraging existing hospital imaging equipment or the XV Scanner. The firm’s revenue comes from SaaS subscriptions and software licensing for its imaging solutions. I-MED Radiology Network is a key client, with 4DMedical initiating the commercial rollout of XV LVAS within its network. The company provides lung imaging technology to selected clinics across I-MED, utilizing the XV Scanner or existing hospital equipment. Revenue streams are derived from the SaaS delivery model, with no mention of additional products or services beyond XV LVA and CT LVAS. 4DMedical’s flagship technology powers dynamic lung ventilation analysis, enabling physicians to identify respiratory issues earlier. The company’s products are designed for use with existing hospital imaging systems, reducing the need for additional hardware. The primary buyers are medical imaging providers like I-MED, which integrate XV Technology into their diagnostic services for respiratory conditions. 4DMedical is one of the most popular companies on Eulerpool.